Centanafadine Uses, Dosage, Side Effects and more
Centanafadine is under investigation in clinical trial NCT02827513 (A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects).
Trade Name | Centanafadine |
Generic | Centanafadine |
Centanafadine Other Names | Centanafadine |
Type | |
Formula | C15H15N |
Weight | Average: 209.292 Monoisotopic: 209.120449487 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |